Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,189
datasets available to search
ShareScore release 0.9.0
Dataset results
2,189 results for “AML”
Talazoparib for Cohesin-Mutated AML and MDS With Excess Blasts
ClinicalTrials.gov study NCT03974217. IPD Sharing: YES. Countries: 1. Publications: 0.
Midostaurin Access Program for Newly Diagnosed FLT3 (ITD or TKD) Mutated AML Adult Patients Eligible for Standard Induction and Consolidation Chemotherapy
ClinicalTrials.gov study NCT02624570. IPD Sharing: Not stated. Countries: 1. Publications: 1.
CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploidentical Donor Natural Killer (NK) Cell Based Therapy for AML Patients Not in CR
ClinicalTrials.gov study NCT03152526. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Alvocidib in Patients With Relapsed/Refractory AML Following Treatment With Venetoclax Combination Therapy
ClinicalTrials.gov study NCT03969420. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia (AML) Following Initial Treatment
ClinicalTrials.gov study NCT05628623. IPD Sharing: NO. Countries: 0. Publications: 21.
Combination 5-azacitidine and Gemtuzumab Ozogamicin Therapy for Treatment of Relapsed Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00766116. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Best Supportive Care as Maintenance Therapy in Japanese Participants With Acute Myeloid Leukemia (AML) i
ClinicalTrials.gov study NCT05197426. IPD Sharing: Not stated. Countries: 2. Publications: 0.
The Rapid Study: Randomized Phase II Study To Expedite Allogeneic Transplant With Immediate Haploidentical Plus Unrelated Cord Donor Search Versus Matched Unrelated Donor Search For AML And High-Risk
ClinicalTrials.gov study NCT02648932. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Alternating Regimen of VA and Low-dose CHA in the Treatment of Unfit Newly Diagnosed AML
ClinicalTrials.gov study NCT07172204. IPD Sharing: YES. Countries: 1. Publications: 0.
AG-013736 (Axitinib) In Patients With Poor Prognosis Acute Myeloid Leukemia (AML) Or Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00071006. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Metformin+Cytarabine for the Treatment of Relapsed/Refractory AML
ClinicalTrials.gov study NCT01849276. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Psychological Mobile App for Patients With AML
ClinicalTrials.gov study NCT05501171. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of MLN9708 as Maintenance Therapy for Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS) in Remission
ClinicalTrials.gov study NCT02302846. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CIML NK Cells With Venetoclax for AML
ClinicalTrials.gov study NCT06152809. IPD Sharing: YES. Countries: 1. Publications: 0.
MEK Inhibitor 162 Relapsed and/or Refractory Acute Myeloid Leukemia (AML) and Poor Prognosis, Not Suitable for or Unwilling to Receive Standard Therapy
ClinicalTrials.gov study NCT02089230. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combined With Filgrastim for Children and Young Adults With AML, MDS and Related Myeloi
ClinicalTrials.gov study NCT05796570. IPD Sharing: YES. Countries: 1. Publications: 0.
Clofarabine and Ara-C for the Treatment of Relapsed AML and Untreated MDS
ClinicalTrials.gov study NCT00334074. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Temozolomide Plus Vorinostat in Relapse/Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01550224. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT05756777. IPD Sharing: YES. Countries: 1. Publications: 0.
Ziftomenib + Mezigdomide in Adolesc. and Adults w/ R/R AML
ClinicalTrials.gov study NCT07355335. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.